On March 1, 2019, the Board of Directors (the “Board”) of Urovant Sciences Ltd. (the “Company”) appointed James Robinson as a member of the Board, effective immediately. He has held the position of President and Chief Operating Officer at Alkermes, where he is responsible for the global commercial, new product planning, corporate planning, manufacturing, quality, human resource and business development functions. Prior to Alkermes, Mr. Robinson spent over 13 years at Astellas US most recently as President, Americas Operations, from April 2016 through February 2018. Additionally, Mr. Robinson is expected to be appointed as a member of the Audit Committee.